Product Description
Discover the wondrous efficacy of Lapatinib Tablets IP Lupin, a triumphant choice in cancer care. Supplied in special blister packs of 30 tablets per carton (or as prescribed), each supreme film-coated yellow tablet holds 250 mg Lapatinib, a dual tyrosine kinase inhibitor. Intended for adults and exclusively prescription-only (Schedule H), this product is vital in the treatment of HER2-positive metastatic breast cancer. With competitive pricing, ensure your patients receive optimal targeted therapy. Add to Cart now for superior results and reliable global supply from India.
Application Areas and Special Features of Lapatinib Tablets IP Lupin
Lapatinib Tablets IP Lupin is specially designed for oral administration in adult patients suffering from HER2-positive metastatic breast cancer. As a dual tyrosine kinase inhibitor, this targeted therapy is often used in combination with other treatments for maximum efficacy. Its supreme formulation provides a focused approach to cancer care, minimizing collateral damage to healthy cells. Convenient blister packaging and clearly marked batch, expiry, and manufacturing details ensure traceability and quality during use and storage.
Sample Availability, Delivery Time, and Export Markets
Samples of Lapatinib Tablets IP Lupin are available for evaluation upon qualified request. Our streamlined order processing and attentive logistics ensure products are handed over promptly to trusted couriers for swift delivery. Timelines for delivery typically depend on the destination, but we pride ourselves on efficiency and professional handling. Our main export markets cover numerous regions, ensuring the product is delivered reliably to healthcare institutions and authorized traders worldwide.
FAQ's of Lapatinib Tablets Ip Lupin:
Q: How should Lapatinib Tablets IP Lupin be administered?
A: Lapatinib Tablets IP Lupin must be taken orally, exactly as prescribed by your healthcare professional, and usually in combination with other therapies for HER2-positive metastatic breast cancer.
Q: What are the main benefits of using Lapatinib Tablets IP Lupin?
A: The main benefit is its targeted mechanism as a dual tyrosine kinase inhibitor, offering a focused and effective treatment for HER2-positive metastatic breast cancer with minimized impact on healthy tissue.
Q: When should I avoid taking this medication?
A: Avoid Lapatinib Tablets IP Lupin if you have known hypersensitivity to lapatinib or any of the tablet's excipients. Always consult with your physician about your medical history before starting the therapy.
Q: Where can I find the batch number and expiry date for Lapatinib Tablets IP Lupin?
A: The batch number, expiry date, and manufacturing date are provided on each carton and blister pack, ensuring transparency and product quality tracking for users and healthcare providers.
Q: What precautions are necessary while using Lapatinib Tablets IP Lupin?
A: Special medical supervision is essential, as the medicine may interact with other drugs. Only take Lapatinib under the direct care of a qualified health professional to monitor for potential side effects or contraindications.